Harpreet Kaur Rai , George Goucher , Jehonathan H. Pinthus , Phillip Williams
{"title":"Primary large cell neuroendocrine carcinoma of the distal ureter: A rare entity","authors":"Harpreet Kaur Rai , George Goucher , Jehonathan H. Pinthus , Phillip Williams","doi":"10.1016/j.ehpc.2021.200545","DOIUrl":null,"url":null,"abstract":"<div><p>Large cell neuroendocrine carcinoma (LCNEC) of the ureter is an extremely rare entity. Herein, we present a case of primary LCNEC of the distal ureter in an 80-year-old male with a history of intermittent hematuria and a mass in the right distal ureter on computed tomography of the abdomen and pelvis. The patient subsequently underwent surgery followed by adjuvant chemotherapy. Histology and immunohistochemistry were in accordance with LCNEC.</p></div>","PeriodicalId":38075,"journal":{"name":"Human Pathology: Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehpc.2021.200545","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Pathology: Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214330021000742","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Large cell neuroendocrine carcinoma (LCNEC) of the ureter is an extremely rare entity. Herein, we present a case of primary LCNEC of the distal ureter in an 80-year-old male with a history of intermittent hematuria and a mass in the right distal ureter on computed tomography of the abdomen and pelvis. The patient subsequently underwent surgery followed by adjuvant chemotherapy. Histology and immunohistochemistry were in accordance with LCNEC.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
